Onyx contracted for API R&D and manufacturing by UK cancer charity
Onyx Scientific has been contracted to develop and manufacture APIs for clinical trials by charitable group Cancer Research UK.
Archives for July 22, 2014
Accovion continues expansions across Europe
Germany-based full-service CRO (contract research organization) Accovion has expanded European presence with new offices in Italy, France and Eastern Europe.
MonosolRx finds new licensee for oral film delivered ondansetron
MonosolRx has found a new US licensee for its oral film ondansetron product, Zuplenz, signing up Galena BioPharma nearly four years after previous partner Strativa handed the drug back.
USFDA approves Novasep facilities for kinase inhibitor contract
Novasep has received the regulatory nod to manufacture a kinase inhibitor new molecular entity (NME) following pre-approval inspections at two facilities in France.
Biosimilar trials: the ‘under the radar’ sourcing race
Timescales and sourcing comparator biologics are the biggest challenges for biopharmas running biosimilars studies, says an expert.
European Pharmacopoeia plans revisions of elemental impurities guideline
As the International Conference on Harmonisation (ICH) signs off on a new tripartite guideline related to elemental impurities, the European Pharmacopoeia Commission will revise its texts to ensure consistency.
Lilly swaps dry powders for insulin at Indiana site in post-patent shake-up
Patent expiration and a large molecule pipeline has prompted Eli Lilly to repurpose a solid oral dose plant in Indiana.
Generics: change in pill shape makes patients 66% more likely to quit
Switching patients to generic pills of a different shape and colour increases the chances they will end their course of medicine early, according to research.
ADHD API sales up, specialty opiates down at Johnson Matthey in Q1
Johnson Matthey’s API business had a mixed fiscal Q1 with gains made in ADHD ingredients and bulk opiates being accompanied by a decline in revenue from specialty opiates.